Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 9/2008

01-09-2008 | Editorial

Congenital rubella: citation virus or viral cause of type 1 diabetes?

Author: E. A. M. Gale

Published in: Diabetologia | Issue 9/2008

Login to get access

Excerpt

There is something worse than ignorance, and that’s knowing what ain’t so
Mark Twain
…
Literature
1.
Menser MA, Forrest JM, Honeyman MC (1974) Diabetes, HL-A antigens, and congenital rubella. Lancet 1974(2):1508–1509CrossRef
2.
Wolinsky JS, McCarthy M (1995) Rubella. In: Porterfield JS (ed) Handbook of infectious diseases: exotic viral infections. Chapman and Hall, London, pp 19–45
3.
O’Donnell N (1996) History of the congenital rubella syndrome. J Vocat Rehabil 6:149–157CrossRef
4.
Burgess MA (1991) Gregg’s rubella legacy 1941–1991. Med J Australia 155:355–356PubMed
5.
6.
Sever JL, Nelson KB, Gilkeson MR (1965) Rubella epidemic, 1964: effect on 6,000 pregnancies. Am J Dis Child 110:395–407PubMed
7.
McEvoy RC, Fedun B, Cooper LZ et al (1988) Children at high risk of diabetes mellitus: New York studies of families with diabetes and of children with congenital rubella syndrome. Adv Exp Med Biol 246:221–227PubMed
8.
9.
Chiriboga-Klein S, Oberfield SE, Casullo AM et al (1989) Growth in the congenital rubella syndrome and correlation with clinical manifestations. J Pediatr 115:251–255PubMedCrossRef
10.
Gregg NM (1941) Congenital cataract following German measles in the mother. Trans Ophthal Soc Aust 3:35–46
11.
Smithdas RJ (1980) Reflections of a deaf-blind adult. Am Ann Deaf 125:1015–1017PubMed
12.
Lockett T, Rudolph J (1980) Deaf-blind children with maternal rubella: implications for adult services. Am Ann Deaf 125:1002–1006PubMed
13.
Trybus RJ, Karchmer MA, Kerstetter PP, Hicks W (1980) The demographics of deafness resulting from maternal rubella. Am Ann Deaf 125:977–984PubMed
14.
Cutts FT, Best J, Siquiera MM, Engstrom K, Robertson SE (1999) Guidelines for surveillance of congenital rubella syndrome and rubella. World Health Organisation, Geneva
15.
Olsen GB, Dent PB, Rawls WE et al (1968) Abnormalities of in vitro lymphocyte responses during rubella virus infections. J Exp Med 128:47–68CrossRef
16.
Rabinowe SL, George KL, Loughlin R, Soeldner JS, Eisenbarth GS (1986) Congenital rubella. Monoclonal antibody-defined T cell abnormalities in young adults. Am J Med 81:779–782PubMedCrossRef
17.
Hay DR (1949) The relation of maternal rubella to congenital deafness and other abnormalities in New Zealand. New Zealand Med J 48:604–608PubMed
18.
Menser A, Dods L, Harley JD (1967) A twenty-five-year follow-up of congenital rubella. Lancet 2:1347–1350PubMedCrossRef
19.
Forrest JM, Menser MA, Harley JD (1969) Diabetes mellitus and congenital rubella. Pediatrics 44:445–447PubMed
20.
Forrest JM, Menser MA, Burgess JA (1971) High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 2:332–334PubMedCrossRef
21.
Plotkin SA, Kaye R (1970) Diabetes mellitus and congenital rubella. Pediatrics 46:650–651PubMed
22.
Johnson GM, Tudor RB (1970) Diabetes mellitus and congenital rubella infection. Am J Dis Child 120:453–455PubMed
23.
Halvorson EP (1977) Diabetes mellitus and congenital rubella: report of a case. Mt Sinai J Med 44:566–567PubMed
24.
Smithells RW, Sheppard S, Marshall WC, Peckham C (1978) Congenital rubella and diabetes mellitus. Lancet 1:439CrossRef
25.
Floret D, Rosenberg D, Hage GN, Monnet P (1980) Hyperthyroidism, diabetes mellitus and the congenital rubella syndrome. Acta Paediatr Scand 69:259–261PubMedCrossRef
26.
Jenson AB, Rosenberg HS, Notkins AL (1980) Pancreatic islet-cell damage in children with fatal viral infections. Lancet 2:354–358PubMed
27.
Patterson K, Chandra RS, Jenson AB (1981) Congenital rubella, insulitis, and diabetes mellitus in an infant. Lancet 1:1048–1049PubMedCrossRef
28.
Schopfer K, Matter L, Flueler U, Werder E (1982) Diabetes mellitus, endocrine autoantibodies, and prenatal rubella infection. Lancet 2:159PubMedCrossRef
29.
Takasu N, Ikema T, Komiya I, Mimura G (2005) Forty-year observation of 280 Japanese patients with congenital rubella syndrome. Diabetes Care 28:2331–2332PubMedCrossRef
30.
31.
Forrest JM, Turnbull FM, Sholler GF et al (2002) Gregg’s congenital rubella patients 60 years later. Med J Aust 177:664–667PubMed
32.
Rubinstein P, Walker ME, Fedun B, Witt ME, Cooper LZ, Ginsberg-Fellner F (1982) The HLA system in congenital rubella patients with and without diabetes. Diabetes 31:1088–1091PubMedCrossRef
33.
Ginsberg-Fellner F, Witt ME, Fedun B et al (1985) Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. Rev Infect Dis 7(Suppl 1):S170–S176PubMed
34.
Shaver KA, Boughman JA, Nance WE (1985) Congenital rubella syndrome and diabetes: a review of epidemiologic, genetic and immunologic factors. Am Ann Deaf 130:526–532PubMed
35.
Fine PEM, Adelstein AM, Snowman J, Clarkson JA, Evans SM (1985) Long term effects of exposure to viral infections in utero. BMJ 290:509–511PubMed
36.
Canadian Deafblind and Rubella Association (1998) A survey of late emerging manifestations of congenital rubella in Canada. Available from http://​www.​cdbra.​ca, accessed 30 June 2008
37.
Honeyman MC, Dorman DC, Menser MA, Forrest JM, Guinan JJ, Clark P (1975) HL-A antigens in congenital rubella and the role of antigens 1 and 8 in the epidemiology of natural rubella. Tissue Antigens 5:12–18PubMed
38.
Kato S, Kimura M, Takakura I, Tsuji K, Ueda K (1980) HLA-linked genetic control in natural rubella infection. Tissue Antigens 15:86–89PubMedCrossRef
39.
Shaver KA, Boughman JA, Kenyon N, Mohanakumar T, Nance WE (1984) HLA antigens in the congenital rubella syndrome. Dis Markers 2:381–391
40.
Viskari H, Paronen J, Keskinen P et al (2003) Humoral β-cell autoimmunity is rare in patients with the congenital rubella syndrome. Clin Exp Immunol 133:378–383PubMedCrossRef
41.
De Prins F, Van Assche FA, Desmyter J, De Groote G, Gepts W (1978) Congenital rubella and diabetes mellitus. Lancet 2:439–440
42.
Ward KP, Galloway WH, Auchterlonie IA (1979) Congenital cytomegalovirus infection and diabetes. Lancet 1:497PubMedCrossRef
43.
Ivarsson SA, Linberg B, Nilsson KO, Ahlfors K, Svanberg L (1993) The prevalence of type 1 diabetes at follow-up of Swedish infants congenitally infected with cytomegalovirus. Diabet Med 10:521–523PubMed
44.
Gale EAM, Atkinson M (2004) A piece of nucleic acid surrounded by controversy: coxsackievirus and the causes of type 1 diabetes. Diabet Med 21:503–506PubMedCrossRef
45.
Meier JJ, Butler AE, Saisho Y et al (2008) Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta cell mass in humans. Diabetes 57:1584–1594PubMedCrossRef
Metadata
Title
Congenital rubella: citation virus or viral cause of type 1 diabetes?
Author
E. A. M. Gale
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1099-4

Other articles of this Issue 9/2008

Diabetologia 9/2008 Go to the issue

Article

Children developing type 1 diabetes before 6 years of age have increased linear growth independent of HLA genotypes

Commentary

Is a nutritional therapeutic approach unsuitable for metabolically healthy but obese women?

Article

Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis

Short Communication

Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?

Short Communication

Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps

Review

Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits